Best PT-141 Providers in 2026 — Ranked & Reviewed
PT-141 (bremelanotide) is prescribed for low sexual desire and works through the central melanocortin pathway rather than blood flow, which is what distinguishes it from the ED medications it often sits alongside. It requires a prescription. Every provider below prescribes it through a licensed clinician and is scored on the same dimensions as the rest of our catalog.
27 providers compared
New to PT-141? Read our full PT-141 guide — evidence, dosing, safety and side effects.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
27 pt-141 providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
Science-forward GLP-1 and peptide care nationwide, with flat-rate dosing and built-in clinical follow-up
From /moCheck pricingCoverage50 statesMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinNAD+PT-141SermorelinTB-500Tesamorelin Bryan Johnson's longevity telehealth: compounded sema/tirz microdose injections from $167/mo
From /moCheck pricingCoverageCheck intakeMedicationsGlutathioneNAD+PT-141Sermorelincompounded and brand-name GLP-1 plus a longevity stack on one platform
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+PT-141Sermorelin- Best Budget
Needle-free and microdosed compounded GLP-1 options with lab-monitored care
From /moCheck pricingCoverageCheck intakeMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuIpamorelinNAD+PT-141SermorelinTB-500 Shoppers wanting compounded GLP-1 within a lab-driven longevity and hormone clinic
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+PT-141Sermorelinadults wanting physician-led compounded GLP-1 care with labs, follow-up, and peptide options included
From /moCheck pricingCoverageCheck intakeMedicationsNAD+SermorelinGlutathioneGonadorelinPT-141patients prioritizing regulatory compliance in the compounded space
From /moCheck pricingCoverageCheck intakeMedicationsBPC-157NAD+PT-141TB-500concierge GLP-1 with a 91-biomarker lab panel and hormone optimization
From /moCheck pricingCoverageCheck intakeMedicationsGlutathioneGonadorelinNAD+PT-141
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick Science-forward GLP-1 and peptide care nationwide, with flat-rate dosing and built-in clinical follow-up | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinNAD+PT-141SermorelinTB-500Tesamorelin | 50 states | Visit → | |
 Bryan Johnson's longevity telehealth: compounded sema/tirz microdose injections from $167/mo | Check pricing | GlutathioneNAD+PT-141Sermorelin | Check intake | Visit → | |
 compounded and brand-name GLP-1 plus a longevity stack on one platform | Check pricing | GHK-CuGlutathioneNAD+PT-141Sermorelin | Check intake | Visit → | |
Best Budget Needle-free and microdosed compounded GLP-1 options with lab-monitored care | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuIpamorelinNAD+PT-141SermorelinTB-500 | Check intake | Visit → | |
 Shoppers wanting compounded GLP-1 within a lab-driven longevity and hormone clinic | Check pricing | GHK-CuGlutathioneNAD+PT-141Sermorelin | Check intake | Visit → | |
 adults wanting physician-led compounded GLP-1 care with labs, follow-up, and peptide options included | Check pricing | NAD+SermorelinGlutathioneGonadorelinPT-141 | Check intake | Visit → | |
PE PeptidesRxpatients prioritizing regulatory compliance in the compounded space | Check pricing | BPC-157NAD+PT-141TB-500 | Check intake | Visit → | |
 concierge GLP-1 with a 91-biomarker lab panel and hormone optimization | Check pricing | GlutathioneGonadorelinNAD+PT-141 | Check intake | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
A note on prices below: any dollar figure in these provider summaries refers to that clinic’s GLP‑1 weight-loss program, not to PT-141. Peptide pricing is rarely published up front — check the provider’s own site for current cost.
YourHealthRx
Best for: Science-forward GLP-1 and peptide care nationwide, with flat-rate dosing and built-in clinical follow-up
YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network. Compounded semaglutide and tirzepatide come as a weekly injectable (with B12) or a daily oral tablet, at a flat subscription price that doesn't change with your dose - injectable semaglutide ~$170/mo and tirzepatide ~$210/mo ongoing. It also offers a broad peptide catalog plus lab testing. Prescribing runs through partner clinical workflows; compounded meds aren't FDA-approved, the pharmacy isn't named, and no LegitScript is shown.
Score Breakdown
Pros
- ✓Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
- ✓Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
- ✓Flat subscription price that doesn't change as your dose increases (no titration penalty)
- ✓Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
- ✓Transparent, education-first positioning with published medical disclaimer, privacy, and terms
Cons
- ✗Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
- ✗Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
- ✗Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
- ✗No LegitScript certification displayed
Immortals
Best for: Bryan Johnson's longevity telehealth: compounded sema/tirz microdose injections from $167/mo
Immortals is a LegitScript-certified longevity telehealth platform founded by Bryan Johnson, offering compounded semaglutide (Semaglutide/Glycine/B12) and tirzepatide (Tirzepatide/Glycine/B12) as microdose weekly injections. Every subscription includes physician review within 72 hours, prescription fulfillment from licensed U.S. pharmacies, discreet shipping, and unlimited provider messaging for 12 months. Semaglutide starts at $167/month and tirzepatide at $180/month (promotional, billed quarterly). HSA/FSA reimbursable; no insurance required.
Score Breakdown
Pros
- ✓LegitScript certified (ID 50458743) with board-certified U.S. physician review within 72 hours
- ✓Physician consult + prescription bundled in price — 'You pay for treatment. That's it' with no added fees
- ✓Competitive pricing: semaglutide microdose from $167/month, tirzepatide from $180/month (promotional)
- ✓Unlimited provider messaging for 12 months included; video consults available
- ✓Founded by Bryan Johnson and Kate Tolo; clinical lead Dr. Carl Seger, M.D. (preventive/longevity medicine)
Cons
- ✗Microdose framing uses sub-clinical doses — lower weight-loss efficacy than standard GLP-1 protocols
- ✗Quarterly commitment only — 3-month minimum, paid upfront ($501–$540/quarter); no monthly flexibility
- ✗State availability not publicly listed; 'eligible U.S. states' with no specific state list
- ✗Labs not included; baseline bloodwork protocol not disclosed on any public page
- ✗Compounding pharmacy not named; no 503A/503B accreditation details disclosed
Kin Meds
Best for: compounded and brand-name GLP-1 plus a longevity stack on one platform
Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and pill, Zepbound and Foundayo from $149/mo. Beyond weight loss, it bundles a longevity and wellness menu — Sermorelin, NAD+, glutathione, TRT, plus hair, skin and sexual health — so members can manage multiple protocols on one account.
Score Breakdown
Pros
- ✓Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
- ✓Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
- ✓LegitScript verified
- ✓Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
- ✓Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health
- ✓Telehealth flow clearly disclosed: questionnaire, provider review, tailored plan, ongoing support
Cons
- ✗Legal entity name and state of incorporation not publicly disclosed
- ✗The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
- ✗Per-state availability not listed
- ✗$149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
- ✗Lab work and dose-titration support not clearly described
- ✗Breadth across 8+ categories signals a broad DTC platform, not a GLP-1 specialist
Telos Rx
Best for: Needle-free and microdosed compounded GLP-1 options with lab-monitored care
Telos Rx is a compounded telehealth platform (Superior Health Solutions LLC) offering GLP-1 weight loss alongside longevity, recovery, and sexual-health peptides. Its GLP-1 line includes compounded semaglutide and tirzepatide injections plus needle-free sublingual and microdosed tirzepatide, with provider dose adjustments, lab monitoring, free discreet shipping, FSA/HSA, and cancel-anytime. Headline prices are first-month intro rates (from $49); ongoing cost is higher. Compounded meds are not FDA-approved; pharmacy and states unpublished; no LegitScript shown.
Score Breakdown
Pros
- ✓Multiple GLP-1 modalities: compounded semaglutide and tirzepatide injections plus needle-free sublingual and microdosed tirzepatide
- ✓Provider-led dose adjustments and lab monitoring as your protocol changes
- ✓Free discreet, temperature-controlled shipping (no Telos branding on the outside)
- ✓FSA/HSA eligible and cancel anytime in one click
- ✓Trustpilot rating of 4.9; full compliance suite published (Privacy, Terms, HIPAA, Shipping & returns)
- ✓Integrated care team spanning weight loss, longevity, recovery, and sexual health (peptide-led)
Cons
- ✗Headline pricing is 'first month low as' intro pricing (semaglutide $49, tirzepatide $99) — ongoing monthly cost is higher and shown during intake
- ✗Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗Compounding pharmacy partner is not named
- ✗State-availability list is not published
- ✗No LegitScript certification displayed
iThriveMD
Best for: Shoppers wanting compounded GLP-1 within a lab-driven longevity and hormone clinic
iThriveMD is a longevity and metabolic-health clinic (physical locations plus telehealth) offering compounded GLP-1 weight loss — semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs — alongside hormone therapy (HRT/TRT), NAD+, peptides, IV therapy, sexual health, and diagnostic lab testing. Care is lab-driven with personalized protocols and a free initial consultation; lower 'preferred pricing' is available to members. It publishes a thorough legal/policy suite. The compounding pharmacy is not named and no LegitScript certification is shown.
Score Breakdown
Pros
- ✓Compounded semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs
- ✓Lab testing and personalized protocols with a medical team; free initial consultation
- ✓Very thorough legal/policy suite (Terms, Privacy, EUA, Shipping, Returns, CCPA)
- ✓Broad longevity menu: hormones (HRT/TRT), NAD+, peptides, IV therapy, sexual health, diagnostics
Cons
- ✗Premium pricing — higher than budget compounded-GLP-1 competitors (lowest rates need 'preferred pricing')
- ✗Headline GLP-1 pricing is 'starting at'; full cost depends on dose and program length
- ✗Compounding pharmacy partner not named
- ✗Not LegitScript-certified (no certification displayed)
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.